NantHealth, Inc
NH was delisted on the 23rd of May, 2023.
46 hedge funds and large institutions have $9.06M invested in NantHealth, Inc in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 9 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
6% less funds holding
Funds holding: 49 → 46 (-3)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
56% less capital invested
Capital invested by funds: $20.5M → $9.06M (-$11.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $100K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$203K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$104K |
| 3 |
BlackRock
New York
|
+$91K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$71.7K |
| 5 |
State Street
Boston,
Massachusetts
|
+$40.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.07M |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
-$581K |
| 3 |
TTSTC
Texas Treasury Safekeeping Trust Company
Austin,
Texas
|
-$88K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$64.8K |
| 5 |
Goldman Sachs
New York
|
-$55.4K |
NH Hedge Fund Activity: Q3 2018 in Review
46 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q3 2018, worth a combined $9.06M — down 56% from $20.5M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NH and 6 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 15 added.
The largest buyer was Jacobs Levy Equity Management, adding an estimated $203K. The largest seller was Morgan Stanley, cutting an estimated $1.07M.
- 46 institutional investors held NantHealth, Inc (NH) as of Q3 2018, down from 49 in Q2 2018.
- Funds reported $9.06M of NantHealth, Inc stock for Q3 2018, down 56% quarter-over-quarter.
- 6 funds opened new NantHealth, Inc positions in Q3 2018 and 9 closed out, a net change of -3 holders.
- The largest NantHealth, Inc buyer in Q3 2018 was Jacobs Levy Equity Management, an estimated $203K added.
- The largest NantHealth, Inc seller in Q3 2018 was Morgan Stanley, an estimated $1.07M sold.
Based on aggregated 13F filings for Q3 2018.